Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DSHEA Sheds Little Light On Distinguishing Old From New Ingredients

This article was originally published in The Tan Sheet

Executive Summary

Former Senate staffer Patricia Knight, who helped write DSHEA, says her “one regret” about the act passed in 1994 is “something we left out, how to prove, how to lock in what was on the market.” There is just no way for the FDA to figure out what was on the market then,” she says.


Related Content

FTC Requests Drug Claim Support For Bayer Probiotic Supplement
Omega-3 Questions Could Pull Plug On Sales Growth
FDA Revision Of NDI Draft Guidance Starts With Grandfathered List


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts